FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2317353040> ?p ?o ?g. }

• W2317353040 endingPage "130" @default.
• W2317353040 startingPage "126" @default.
• W2317353040 abstract "Idiopathic intracranial hypertension (IIH) is a neurological disorder characterized by elevated intracranial pressure of unknown cause. Acetazolamide is widely used as the initial treatment option; however, previously published evidence suggests that this drug may also increase the risk of nephrolithiasis. The purpose of this study was to examine daily acetazolamide use and its relationship to nephrolithiasis and compare clinical presentation of IIH between those with and without nephrolithiasis.We conducted a case-control study using patient data collected by the Intracranial Hypertension Registry. A total of 670 patients were identified as potential study participants, 19 meeting the case definition of developing a stone during acetazolamide treatment for IIH. From the remaining pool of eligible participants, 40 controls were randomly selected. Two-sampled t tests, Fisher exact testing, and exact logistic regression were used to examine differences between cases and controls and to ascertain associations with IIH clinical features and mean daily acetazolamide dosage.Among all eligible patients, 19 (2.8%) developed a stone during acetazolamide treatment for IIH. Among these patients, 17 (89.5%) developed a stone within 1.5 years of initial acetazolamide treatment. Daily acetazolamide use was not significantly related to stone development (odds ratio = 0.95; 95% confidence intervals: 0.86-1.05). Additionally, the relationship between the clinical presentation of IIH at the time of diagnosis (signs and symptoms) and stone development did not reach statistical significance (P > 0.05).Our results demonstrate that: 1) stone formation during acetazolamide treatment is a relatively infrequent occurrence within the IIH population; 2) among patients who develop a stone, formation is likely to occur within the first year and half; 3) there is no evidence to support the association between acetazolamide daily dosage and stone development; and 4) no unique IIH disease features at the time of diagnosis are associated with stone development. Treatment with acetazolamide should be administered to IIH patients with caution and closely monitored for stone development especially within the first year and a half of treatment." @default.
• W2317353040 created "2016-06-24" @default.
• W2317353040 creator A5003986108 @default.
• W2317353040 creator A5006245595 @default.
• W2317353040 creator A5030643415 @default.
• W2317353040 creator A5053648072 @default.
• W2317353040 creator A5087860751 @default.
• W2317353040 date "2016-06-01" @default.
• W2317353040 modified "2023-10-08" @default.
• W2317353040 title "Acetazolamide-Induced Nephrolithiasis in Idiopathic Intracranial Hypertension Patients" @default.
• W2317353040 cites W1573363840 @default.
• W2317353040 cites W1603035488 @default.
• W2317353040 cites W1965080728 @default.
• W2317353040 cites W1973168212 @default.
• W2317353040 cites W1983548610 @default.
• W2317353040 cites W2050107937 @default.
• W2317353040 cites W2059438266 @default.
• W2317353040 cites W2073011882 @default.
• W2317353040 cites W2080260611 @default.
• W2317353040 cites W2081703969 @default.
• W2317353040 cites W2093084865 @default.
• W2317353040 cites W2106338965 @default.
• W2317353040 cites W2111279651 @default.
• W2317353040 cites W2123143657 @default.
• W2317353040 cites W2160088455 @default.
• W2317353040 cites W2166030341 @default.
• W2317353040 cites W2171942415 @default.
• W2317353040 cites W2225370423 @default.
• W2317353040 cites W2323231098 @default.
• W2317353040 cites W2330496546 @default.
• W2317353040 doi "https://doi.org/10.1097/wno.0000000000000330" @default.
• W2317353040 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26606175" @default.
• W2317353040 hasPublicationYear "2016" @default.
• W2317353040 type Work @default.
• W2317353040 sameAs 2317353040 @default.
• W2317353040 citedByCount "8" @default.
• W2317353040 countsByYear W23173530402016 @default.
• W2317353040 countsByYear W23173530402017 @default.
• W2317353040 countsByYear W23173530402019 @default.
• W2317353040 countsByYear W23173530402020 @default.
• W2317353040 countsByYear W23173530402021 @default.
• W2317353040 crossrefType "journal-article" @default.
• W2317353040 hasAuthorship W2317353040A5003986108 @default.
• W2317353040 hasAuthorship W2317353040A5006245595 @default.
• W2317353040 hasAuthorship W2317353040A5030643415 @default.
• W2317353040 hasAuthorship W2317353040A5053648072 @default.
• W2317353040 hasAuthorship W2317353040A5087860751 @default.
• W2317353040 hasConcept C126322002 @default.
• W2317353040 hasConcept C141071460 @default.
• W2317353040 hasConcept C156957248 @default.
• W2317353040 hasConcept C187212893 @default.
• W2317353040 hasConcept C2777405951 @default.
• W2317353040 hasConcept C2777601897 @default.
• W2317353040 hasConcept C44249647 @default.
• W2317353040 hasConcept C71924100 @default.
• W2317353040 hasConceptScore W2317353040C126322002 @default.
• W2317353040 hasConceptScore W2317353040C141071460 @default.
• W2317353040 hasConceptScore W2317353040C156957248 @default.
• W2317353040 hasConceptScore W2317353040C187212893 @default.
• W2317353040 hasConceptScore W2317353040C2777405951 @default.
• W2317353040 hasConceptScore W2317353040C2777601897 @default.
• W2317353040 hasConceptScore W2317353040C44249647 @default.
• W2317353040 hasConceptScore W2317353040C71924100 @default.
• W2317353040 hasIssue "2" @default.
• W2317353040 hasLocation W23173530401 @default.
• W2317353040 hasLocation W23173530402 @default.
• W2317353040 hasOpenAccess W2317353040 @default.
• W2317353040 hasPrimaryLocation W23173530401 @default.
• W2317353040 hasRelatedWork W2003938723 @default.
• W2317353040 hasRelatedWork W2047967234 @default.
• W2317353040 hasRelatedWork W2118496982 @default.
• W2317353040 hasRelatedWork W2364998975 @default.
• W2317353040 hasRelatedWork W2369162477 @default.
• W2317353040 hasRelatedWork W2439875401 @default.
• W2317353040 hasRelatedWork W4238867864 @default.
• W2317353040 hasRelatedWork W2525756941 @default.
• W2317353040 hasRelatedWork W4214799196 @default.
• W2317353040 hasRelatedWork W4214955067 @default.
• W2317353040 hasVolume "36" @default.
• W2317353040 isParatext "false" @default.
• W2317353040 isRetracted "false" @default.
• W2317353040 magId "2317353040" @default.
• W2317353040 workType "article" @default.